Article Text

Download PDFPDF
Response to: ‘Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia’ by Morton and Thompson

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors TBP drafted the letter. All authors revised the letter and approved the final version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests AGE holds a HCF Research Foundation Professorial Research Fellowship and receives income as a Ministerial appointee to the (Australian) Medicare Benefits Schedule (MBS) Review Taskforce, as a Board Member of the NSW Bureau of Health Information (BHI) and as a consultant to Private Healthcare Australia and the Queensland and Victoria state health departments. TB-P has received consulting fees from Queensland Health and the Victorian Department of Health and Human Services.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles